Back to Insights
Industry March 23, 2026 · 35 min read

Korean Medical Device Market Overview

Korean Medical Device Market Overview

Key Takeaway

South Korea's medical device market, valued at USD $7.57 billion in 2025 and projected to reach USD $12.58 billion by 2032 (CAGR: 7.5%), offers Canadian medtech companies a high-value direct market opportunity and a credentialed gateway into broader Asia. Key demand drivers include rapid population aging, a government-backed bio-health export strategy targeting USD $30 billion by 2030, and universal NHI coverage — all of which create favorable and sustained conditions for foreign medical device entry.

# Korean Medical Device Market Overview

South Korea is one of the most advanced and rapidly growing medical device markets in Asia, driven by a world-class healthcare system, an aging population with rising chronic disease prevalence, government investment in bio-health as a strategic growth sector, and a domestic medtech industry that is increasingly competitive globally. For Canadian medical technology companies, Korea represents both a significant direct market opportunity and a gateway to broader Asian markets.

This report examines the Korean medical device market's size, structure, key domestic players, import dynamics, growth segments, and the strategic factors that Canadian companies should understand before pursuing market entry.

---

Part 1: Market Size and Growth Trajectory

Current Market Scale

The South Korean medical device market was valued at approximately USD $7.57 billion in 2025, making it one of the largest medical device markets in Asia after China and Japan. The market is projected to grow at a compound annual growth rate (CAGR) of 7.5 percent, reaching USD $12.58 billion by 2032.

Korea's medical device market represents approximately 2–3 percent of the global medical device market, but its importance extends beyond raw market size. Korea's advanced healthcare infrastructure, early-adopting clinician base, and demanding regulatory standards make it an important reference market — a medical device that gains Korean Ministry of Food and Drug Safety (MFDS) approval and achieves commercial traction in Korean hospitals carries credibility that facilitates entry into other Asian markets.

Growth Drivers

Demographic forces: Korea has one of the fastest-aging populations in the world. The country's elderly population (65+) is projected to reach 20 percent of the total population by 2026 and 40 percent by 2050. This demographic shift drives sustained demand growth across virtually all medical device categories — from diagnostic imaging and monitoring devices to orthopedic implants, cardiovascular devices, and home healthcare equipment.

Government bio-health strategy: The Korean government has designated bio-health as one of the country's three strategic growth engines (alongside AI/semiconductors and future mobility). In March 2026, at the Medical Korea 2026 conference, the government announced a target of USD $30 billion in bio-health exports by 2030, with AI-powered medical devices positioned as a key export category. Government investment in digital health infrastructure, AI diagnostic development, and medical device innovation centers provides both demand-side support and supply-side capability building.

Universal healthcare coverage: Korea's National Health Insurance (NHI) system covers the entire population and reimburses a wide range of medical devices and procedures. While NHI reimbursement rates can be challenging (often below the rates seen in the US or Europe), the universal coverage means tha

Implications

Canadian medical technology companies should prioritize MFDS regulatory approval as a strategic asset — not only for Korean market access, but as a credential that strengthens positioning across other Asian markets. The Korean government's bio-health export push and AI diagnostic investment signal strong alignment with Canadian strengths in digital health and AI-enabled devices. Early engagement with Korean hospital networks and reimbursement pathways under the NHI framework will be critical to commercial traction. Given Korea's role as a regional reference market, a well-executed Korean market entry can serve as a scalable platform for broader Asia-Pacific expansion.